Wegovy - Pill (Novo Nordisks Oral GLP-1) Described as the first oral GLP-1 medicine for obesity in the US, the Wegovy pill was granted FDA approval in December 2025
Search Strategy A systematic search of Ovid MEDLINE, Embase, and PubMed was conducted using the terms amyloidosis, gastrointestinal, upper gastrointestinal tract, lower gastrointestinal tract, hepatic, liver, and nutrition as MeSH terms and text words
The same caution applies during pregnancy, and for a defined period before conception
Most likely, if Tirzepatide is taken in a low dosage for a month and then gradually increased, this effect of the peptide on gastric emptying can be prolonged
Both may be contraindicated if you have: Personal or family history of medullary thyroid carcinoma, Multiple Endocrine Neoplasia syndrome type 2, history of severe pancreatitis, current pregnancy or plans to become pregnant, or severe kidney disease
Inform patients that leaving hydrocodone bitartrate and acetaminophen tablets unsecured can pose a deadly risk to others in the home (see WARNINGS, DRUG ABUSE AND DEPENDENCE)
